ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå : Á¦Ç° À¯Çü, °øÁ¤, ÃÖÁ¾»ç¿ëÀÚ, ¿ëµµ, ±¸¼º¿ä¼Òº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Automated Blood Processing Equipment Market by Product Type, Process, End User, Application, Component - Global Forecast 2025-2030
»óǰÄÚµå : 1572104
¸®¼­Ä¡»ç : 360iResearch Private Limited
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,939 £Ü 5,699,000
PDF, Excel & 1 Year Online Access (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 4,249 £Ü 6,147,000
PDF, Excel & 1 Year Online Access (2-5 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿Àϱâ¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 5,759 £Ü 8,332,000
PDF, Excel & 1 Year Online Access (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ Áö¿ª »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 6,969 £Ü 10,083,000
PDF, Excel & 1 Year Online Access (Enterprise User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀåÀº 2023³â 466¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 503¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CAGR 7.92%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 796¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ¼¼°è ½ÃÀå¿¡´Â ºÐ¸®, ¼öÁý, º¸°ü µî Ç÷¾× ó¸® ÀÛ¾÷ÀÇ È¿À²¼º°ú ÇÕ¸®È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ´Ù¾çÇÑ Àåºñ°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº ÀÓ»ó ½ÇÇè½Ç°ú Ç÷¾×ÀºÇàÀÇ Á¤È®¼º°ú ¼Óµµ¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó »ý°Ü³µÀ¸¸ç, ¼ö¼ú Áõ°¡, ¿Ü»ó »ç·Ê ¹× ¸¸¼º ÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ Áõ°¡ÇÏ´Â Ç÷¾× ¼ººÐ¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. º´¿ø, Ç÷¾×ÀºÇà, ½ÇÇè½Ç, Áø´Ü¼¾ÅÍ µî ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµË´Ï´Ù. ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚ¿¡´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ¹× Ç÷¾× ¼öÁý ±â°üÀÌ Æ÷ÇԵǸç, ÇÁ·Î¼¼½º Á¤È®µµ Çâ»ó, ¼öÀÛ¾÷ °¨¼Ò, ¾ÈÀü ±âÁØ °³¼± µîÀÇ ÀÌÁ¡À» ´©¸± ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 466¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 503¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 796¾ï 5,000¸¸ ´Þ·¯
CAGR(%) 7.92%

½ÃÀå ¼ºÀåÀº ±â¼ú ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡, Ç÷¾× Áúȯ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿¡ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÃֽŠºñÁî´Ï½º ±âȸ·Î´Â ÇコÄɾî ÀÎÇÁ¶ó°¡ ±¸ÃàµÇ°í ÀÖ´Â ½ÅÈï ½ÃÀå ÁøÃâ, AI¿Í ¸Ó½Å·¯´×À» Ȱ¿ëÇÑ Á¤±³ÇÑ µ¥ÀÌÅÍ ºÐ¼® ¹× ǰÁú °ü¸® µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÀúÀÚ¿ø ȯ°æ¿¡¼­µµ ÀÛµ¿ÇÒ ¼ö ÀÖ´Â ÈÞ´ë¿ë, º¸´Ù È¿À²ÀûÀÎ ±â±â °³¹ßÀº Á¢±Ù¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ±â±â ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× À¯ÀüÀÚ Á¤º¸ Ãë±Þ¿¡ ´ëÇÑ À±¸®Àû ¹®Á¦ µîÀÌ ¿©ÀüÈ÷ ³²¾ÆÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀ» ÇØ°áÇϱâ À§Çؼ­´Â ¿¬±¸°³¹ß¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ¿Í ±ÔÁ¦±â°ü°úÀÇ Çù·ÂÀû ³ë·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.

Çõ½ÅÀº ÃÖ¼Òħ½À ±â¼ú °³¹ß, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× ¿ø°Ý Á¦¾î ±â´ÉÀ» À§ÇÑ µðÁöÅÐ ±â¼ú ÅëÇÕ¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù. Ç÷¾× ¼ººÐÀÇ º¸Á¸ ±â°£ ¿¬Àå ¹× ¸ê±Õ °øÁ¤ °³¼±¿¡ ´ëÇÑ ¿¬±¸´Â ±â¾÷ÀÇ °æÀï·ÂÀ» ´õ¿í Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ºü¸¥ ±â¼ú Çõ½ÅÀÌ Æ¯Â¡À̸ç, ¹ÎøÇÑ Ç÷¹À̾°Ô´Â ±âȸ°¡ µÇ°í, ºü¸£°Ô ÀûÀÀÇÏÁö ¸øÇÏ´Â Ç÷¹À̾°Ô´Â À§ÇùÀÌ µÉ °ÍÀÔ´Ï´Ù. ±â¾÷µéÀº Á¦Ç° ¶óÀξ÷À» °­È­ÇÏ°í ¼ºÀåÀ» Áö¼ÓÇϱâ À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ¹× ÇÏÀÌÅ×Å© ±â¾÷°ú Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¸Î´Â °ÍÀ» ¿ì¼±¼øÀ§¿¡ µÎ¾î¾ß ÇÕ´Ï´Ù. »ç¿ëÀÚ Ä£È­ÀûÀÎ ¼³°è¿Í ±³Â÷ ºÐ¾ß Çù¾÷¿¡ ÁßÁ¡À» µÎ¸é ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇÏ°í ¾÷°è ¹ßÀüÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Porter's Five Forces : ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÚµ¿Ç÷¾×ó¸®ÀåÄ¡ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀÚµ¿Ç÷¾×ó¸®ÀåÄ¡ ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀü°úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

Á¦6Àå ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦7Àå ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå : ÇÁ·Î¼¼½ºº°

Á¦8Àå ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå : ¿ëµµº°

Á¦10Àå ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå : ±¸¼º¿ä¼Òº°

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÚµ¿ Ç÷¾× ó¸® Àåºñ ½ÃÀå

Á¦14Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Automated Blood Processing Equipment Market was valued at USD 46.69 billion in 2023, expected to reach USD 50.35 billion in 2024, and is projected to grow at a CAGR of 7.92%, to USD 79.65 billion by 2030.

The global market for Automated Blood Processing Equipment encompasses a range of devices designed to streamline and improve the efficiency of blood processing operations such as separation, collection, and storage. This market emerges from the growing necessity for precision and speed in clinical laboratories and blood banks, addressing the increasing global demand for blood components driven by rising surgical procedures, trauma cases, and the prevalence of chronic diseases. Applications extend to hospitals, blood banks, research laboratories, and diagnostic centers. Key end-users include healthcare providers and blood collection organizations, which benefit from enhanced process accuracy, reduced manual intervention, and improved safety standards.

KEY MARKET STATISTICS
Base Year [2023] USD 46.69 billion
Estimated Year [2024] USD 50.35 billion
Forecast Year [2030] USD 79.65 billion
CAGR (%) 7.92%

Market growth is influenced by technological advancements, increased healthcare spending, and heightened awareness of blood disorders. Latest opportunities include expanding into emerging markets with rising healthcare infrastructure and leveraging AI and machine learning for refined data analytics and quality control. There is potential in developing portable and more efficient devices that can operate in low-resource settings, enhancing accessibility. However, challenges persist such as high equipment costs, stringent regulatory standards, and ethical concerns over data privacy and the handling of genetic information. Addressing these factors requires strategic investment in R&D and collaborative efforts with regulatory bodies.

Innovation should focus on developing minimally invasive techniques and integrating digital technologies for real-time monitoring and remote operation capabilities. Research into extending the shelf-life of blood components and improving sterilization processes can further position companies competitively. The market is characterized by rapid technological change, posing both an opportunity for agile players and a threat to those unable to quickly adapt. Companies should prioritize forming strategic partnerships with healthcare providers and tech firms to enhance their offerings and sustain growth. Emphasizing user-friendly designs and cross-sector collaborations can solidify market presence and drive industry advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automated Blood Processing Equipment Market

The Automated Blood Processing Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Porter's Five Forces: A Strategic Tool for Navigating the Automated Blood Processing Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automated Blood Processing Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automated Blood Processing Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automated Blood Processing Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automated Blood Processing Equipment Market

A detailed market share analysis in the Automated Blood Processing Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automated Blood Processing Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automated Blood Processing Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automated Blood Processing Equipment Market

A strategic analysis of the Automated Blood Processing Equipment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automated Blood Processing Equipment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asahi Kasei Medical Co., Ltd., Autogen Inc., B. Braun Melsungen AG, Beckman Coulter, Inc., Becton, Dickinson and Company (BD), Biomedica Grimm GmbH, Cobe Laboratories Inc., Fenwal Inc., Fresenius Kabi AG, Grifols, S.A., Haemonetics Corporation, LivaNova PLC, Macopharma, Medica Corp., Medtronic plc, Stryker Corporation, Terumo BCT Inc., Terumo Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Automated Blood Processing Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Automated Blood Processing Equipment Market, by Product Type

7. Automated Blood Processing Equipment Market, by Process

8. Automated Blood Processing Equipment Market, by End User

9. Automated Blood Processing Equipment Market, by Application

10. Automated Blood Processing Equipment Market, by Component

11. Americas Automated Blood Processing Equipment Market

12. Asia-Pacific Automated Blood Processing Equipment Market

13. Europe, Middle East & Africa Automated Blood Processing Equipment Market

14. Competitive Landscape

Companies Mentioned

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â